# Toremifene in Treating Patients With Desmoid Tumors

> **NCT00002595** · PHASE2 · COMPLETED · sponsor: **Advocate Lutheran General Hospital** · enrollment: 72 (estimated)

## Conditions studied

- Desmoid Tumor

## Interventions

- **DRUG:** toremifene
- **PROCEDURE:** conventional surgery

## Key facts

- **NCT ID:** NCT00002595
- **Lead sponsor:** Advocate Lutheran General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1991-07
- **Primary completion:** 2003-05
- **Final completion:** 2010-09
- **Target enrollment:** 72 (ESTIMATED)
- **Last updated:** 2013-07-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00002595

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00002595, "Toremifene in Treating Patients With Desmoid Tumors". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT00002595. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*